Immune Checkpoint Inhibitors in Hodgkin Lymphoma
Sort by:
Total Health
Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL, MM, and CLL
FEATURING
Marcello Maria Rotta
- 354 views
- July 8, 2024
Rush University Medical Center
Challenges and Treatment Strategies in Advanced Stage Hodgkin Lymphoma
FEATURING
Saira Ahmed
- 49 views
- June 14, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"
FEATURING
Cathy Burton
- 118 views
- June 10, 2024
- 2
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in DLBCL and HL
FEATURING
Julie Erika Haydu
- 336 views
- June 5, 2024
- 4
Yale Cancer Center
Latest Advances in HL and PTCL Treatments
FEATURING
Tarsheen Sethi
- 38 views
- May 15, 2024
Indy Hematology Review
Emerging and Current Treatment for Hodgkin Lymphoma in 2024
FEATURING
Stephen M. Ansell
- 411 views
- April 23, 2024
- 5
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Hodgkin Lymphoma
FEATURING
Alex Herrera
- 68 views
- March 22, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Management of Hodgkin Lymphoma
FEATURING
Jakub Svoboda
- 123 views
- March 13, 2024
Moffitt Cancer Center
2024 Updates on Frontline Treatment of Advanced Stage Hodgkin Lymphoma
FEATURING
Hayder Saeed
- 44 views
- March 6, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Hodgkin Lymphoma: History and Current Management
FEATURING
Carmino De Souza
- 44 views
- February 21, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current Treatments in Relapsed HL
FEATURING
Ganiye BegüL KüPeli
- 36 views
- February 16, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic Hodgkin Lymphoma"
FEATURING
Sanjal Desai
- 93 views
- December 29, 2023
- 1
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment of Older Patients With HL in the Modern Era"
FEATURING
Andrew Evens
- 154 views
- December 19, 2023
- 2
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Optimal Management of R/R cHL - Post-Brentuximab & Checkpoint Inhibitor Failure"
FEATURING
Natalie Grover
- 28 views
- December 15, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage Hodgkin Lymphoma
FEATURING
Amanda Cashen
- 42 views
- December 1, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Current Management of Hodgkin Lymphoma in Europe
FEATURING
Antonello Pinto
- 41 views
- December 1, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Harnessing the Immune System in Patients With Lymphoma
FEATURING
Stephen M. Ansell
- 32 views
- November 21, 2023